Minutes of Meetings -
December 2000
ANIMAL PROCEDURES COMMITTEE APC (2000) 5th Meeting
MINUTES OF THE MEETING HELD ON 13 DECEMBER 2000
At The Home Office
| Present |
|
Professor Banner (Chairman)
Professor Atterwill
Mr Baker
Professor Broom
Professor Bulfield*
Professor D Clark
Mr Gregory
Professor Holland
Dr Jennings
Dr Langley*
Professor Martin
Mr McCracken
Professor McNeilly
Professor Richardson * Professor Bulfield and Dr Langley were delayed,
and joined the meeting during the discussion on item 8. |
Home Office
Mr Cobley
Mr Walsh
Inspectorate
Dr Richmond
Secretariat
Mr West
Mr Bourne
Ms Bacon
Mr Brenner |
1. Apologies for absence
1.1 Apologies were received from Professor Anderson,
Professor S Clark, Professor Dunbar, Professor Flecknell, Professor
Purchase, Professor Turner and Dr Anderson (Inspectorate). The
Chairman welcomed Ms Bacon (Secretariat) on her return from maternity
leave. He noted that Mr Bourne, who had joined the Secretariat as Deputy
Secretary on a temporary basis until the return of Ms Bacon, was shortly
to move to another post in the Home Office. He thanked Mr Bourne for his
work with the Secretariat.
2. Minutes of the meeting of 13 September
2.1 Draft minutes had been circulated to the membership
for comment on 27 September. They were accepted as a correct record. Due
to an oversight the minutes had not yet been placed on the APC website.
The Secretariat would rectify that shortly. Action: Secretariat
3. Matters arising from minutes of 13 September
3.1 Annual report 1999 A corrected Register of
members' interests had been circulated to all recipients of the 1999
report. Professor Broom reported that he wished to declare an additional
interest as he was a member of the Ethical Review Procedure (ERP)
committee for Huntingdon Life Sciences. The Chairman thanked Professor
Broom, and reminded other members that membership of ERPs was a declarable
interest.
3.2 Primates sub-committee The Secretary read
out an e mail from the Chair of the sub-committee, Professor Dunbar, in
which he asked the main Committee for a view on how to take forward the
sub-committee's report which had been presented to the Committee at its
meeting on 28 June. After discussion, it was agreed that Professor Banner,
Professor Dunbar and Dr Jennings would discuss how to take the matter
forward. Action: Secretariat to arrange meeting
3.3 Biotechnology working group Professor Richardson reported
that the working group intended to present its report to the full
Committee at the meeting on 14 February.
3.4 Consultation on Cost/Benefit It was noted
that the consultation letter on Cost/Benefit would be announced by a press
release on Friday 15 December. The Secretariat was asked to circulate to
members a list of those organisations which had been sent the letter, so
that members could identify any omissions and inform the Secretariat. Action:
Secretariat and members
3.5 APC weekend conference 27/28 October. The
Chairman thanked all the members who had attended the weekend conference,
especially those who had given presentations. He said that the Secretariat
was shortly to circulate a pro forma asking for feedback on the weekend
conference. Action: Secretariat
3.6 APC membership Mr Cobley reported that Mr O'Brien
had agreed to a recruitment exercise to identify three new members of the
APC. The first stage was to trawl interested parties for suggested
nominations. He confirmed that the APC membership would be included in
that exercise. Some members said they had particular recommendations. The
Chairman advised them to write to him about those: as a member of the
selection panel he would put forward any views he received. Action:
Members
3.7 Drug labelling A press cutting in INF(00)32
referred to a proposal that the labels on drug containers should indicate
whether the drug had been tested on animals. The Committee noted that the
issue was apparently complex. The Secretariat was asked to obtain further
clarification from the Department of Health, so that the Committee could
return to the subject. Action: Secretariat
4. Infringements (APC(00)18A)
4.1 Mr Walsh introduced the paper, and explained that it referred to 25
infringement cases dealt with centrally in the current year. The
infringements ranged from comparatively minor - eg errors in cage
labelling - to more serious infringements, such as failure to check
whether particular procedures had been authorised. Many of the
infringements were self-reported, or had come to light by internal
monitoring by the establishment. The Chief Inspector said that besides
dealing with each individual case the Inspectorate also sought to identify
trends and to disseminate remedial advice. It was explained that current
practice was to take strong action where unnecessary suffering had been
caused; where the licence holder had not demonstrated contrition; or did
not appear to realise the gravity of the infringement; or in repeated
offences. Revocation was sometimes an indication that the person involved
was not considered capable of functioning safely. Mr Walsh said that the
Home Office was currently working on a more detailed summary of the
infringements, which would be presented to the Committee at the next
meeting.
4.2 Some members expressed the wish that the revised paper should
include information about the effects on the animals' welfare of each
infringement, and which infringements were self-reported. Information
about whether the infringement had been caused by an individual's error
or by a management failure would also be important, as would the incidence
of repeated offences. Naming the establishments concerned might have the
negative effect of discouraging self-reporting, but it was important to
know - perhaps by using a system of numbering each establishment in
order to anonymise them - whether there were establishments which
repeatedly committed infringements. Lastly, members suggested that the
revised paper should include a covering note by the Inspectorate or ABCU
commenting about trends, numbers of cases etc. Action: Secretariat: to
write to ABCU
5. APC/UKXIRA relations (APC(00)19)
5.1 There were two issues - whether the APC could
co-opt an UKXIRA member onto the Primates sub-committee; and whether
information in the possession of the Home Office about xenotransplantation
projects could be passed to UKXIRA. Legal advice was that the first was
possible, but that information obtained in confidence by the Home Office
could not be passed to UKXIRA unless the permission of the licence
holder(s) was obtained. Dr Jennings (a member of UKXIRA) reported that
UKXIRA saw liaison with the APC as of increasing importance. The Committee
agreed that the Secretariat should liaise with the UKXIRA Secretariat and
the Chairman of the Primates sub-committee in order to identify a suitable
member of UKXIRA who might be co-opted onto the Primates sub-committee
when necessary as a source of expert advice on xenotransplantation issues.
A proposal would be put to the Committee at the February meeting. The
Committee also agreed that the Home Office should be advised to take
forward UKXIRA access to information held by the Home Office on
xenotransplantation research by approaching past and present licence
holders. Action: Secretariat & ABCU
6. Report by Education and Training sub-committee on training for
Named Animal Care and Welfare Officers (NACWOs) (APC(00)20)
6.1 Mr Gregory introduced the paper. The sub-committee was proposing
that training for newly appointed NACWOs should be made compulsory, and
had drawn up a draft syllabus for an introductory course. Mr Gregory
clarified that the course would be designed for professional animal
technicians.
6.2 In discussion, it was suggested that the course might need to be
expanded to include more detail about welfare observations and a general
introduction to ethics training. It was agreed that the Chairman would
write to the Minister about the proposals. Action: Secretariat
6.3 The Education and Training sub-committee was engaged in ongoing
work on other matters. The Secretariat was asked to liaise with Professor
Flecknell and present a work programme at the next meeting. Action:
Secretariat
7. APC work programme 2001 (APC(00)21)
7.1 It was agreed that part 4 of the draft programme, which identified
subjects for information papers which might be required, should be taken
forward by the working group on Cost/Benefit. Part 4 could therefore be
deleted from the work programme. Subject to that, the proposed work
programme was agreed, and the Secretariat was asked to place it on the
website. The Secretariat was also asked to fix a date for a weekend
conference in October 2001, to arrange dates of meetings in 2002 and to
inform the Committee at the next meeting. Action: Secretariat
8. Reports by working group on openness (APC(00) 17A &
APC(00)17B)
8.1 The Chairman thanked the chair of the working group, Professor
Atterwill, and the four other members of the group for their hard work
involved in the consultation exercise and the consideration of the large
number of responses.
8.2 Professor Atterwill introduced the discussion. The consultation
letter had been sent out on 13 January 2000 and 2,320 responses had been
received. The working group of five APC members had met eight times
between March and November to consider the advice which should be offered.
The working group were submitting two reports to the main Committee - a
majority report, supported by three of the members of the working group,
and a minority report, supported by the other two members of the working
group.
8.3 After discussion, the Committee noted the continuing disagreements
on various matters, in particular in relation to revisions to the project
licence application form and the publication of results.
8.4 Disclosure of a summary of the project licence application
There was a discussion about revisions to the project licence application
form and it was agreed that the Committee should specify in greater detail
what should be included in a publicly available summary. Dr Jennings
agreed to send the Secretariat a draft note which she had prepared on the
preparation of project licence summaries for local Ethical Review
Processes. The Secretariat was asked to circulate this to the membership. Action:
Dr Jennings and Secretariat
8.5 The Committee discussed the content of the recommendation at
length, and decided that that the Project Licence Application form
should require the inclusion of a summary of the procedures to be
undertaken, and that this summary should be comprehensive and detailed
enough to provide a reader with a clear indication of the costs and
benefits of the project. Such a summary would be perhaps a maximum of two
pages, and would be written in language appropriate to the general reader.
The Committee agreed that such a summary should include:-
- Key objectives and possible benefits of the project;
- Reasons for the need to use animals; what alternatives had been
considered; and why these were not appropriate;
- Reasons for the choice of species and strains;
- Numbers of animals to be used and kept for the specific project;
- What would happen to the animals as a result of the project - a
synopsis of the main adverse effects covering the lifetime experience
of the animal; including factors such as source, husbandry, procedures
and their effects, and eventual fate of the animal;
- Estimated level of the severity of the project;
- Specific measures to minimise adverse effects and improve welfare,
including both husbandry and procedures; and
- How the applicant had weighed the costs against the benefits to
judge whether the use of animals was justified.
8.6 The Committee then discussed the stage at which any summary might
be made public. Disclosure could be at the application stage, or when the
licence was granted. It was noted that there were advantages and
disadvantages to both those options. If the application were made public
at the earlier stage:
- it would give members of the public time to comment before a licence
was granted, so that they could seek to influence the decision making
process;
- animal protection organisations might be able to refer to
possible alternative procedures which had not been considered;
- sight of applications which were ultimately turned down would allow
the public to see that the licensing process was sufficiently
rigorous.
On the other hand, it was suggested that there were
also disadvantages in making an application public before the licence had
been granted:
- it would hamper the iterative process of discussion which went on
between the Home Office and applicants;
- as applications were progressively developed by that iterative
process, more than one version of a changing application would have to
be made public;
- until a licence was granted, the procedure had not been subject to
an exercise of governmental judgement.
8.7 The Committee agreed to advise the Minister that when the Home
Office considered the stage at which a summary of a project licence
application might be made public, the advantages and disadvantages of both
options should be taken into consideration.
8.8 Publication of results Discussion turned on the
practicalities of what was agreed to be a difficult and complicated area.
The Committee noted that positive outcomes of experiments were usually
published in open scientific literature, but projects which yielded no
useful results, or failed to prove a project or principle ("negative
results") were seldom written up - that was true, in particular, of
basic medical research. Failure to publish such results could lead to
unnecessary repetition of animal experimentation.
8.9 Mechanisms for making available information on both
positive and negative research outcomes would differ depending on whether
the research was basic medical research or commercial research. It was
considered that one possible mechanism for basic medical research could be
to record on the ABCU website the results achieved or an explanation of
why the project had been abandoned. However, the effort that that would
entail was not be underestimated and it was thought would contribute
little to academic progress. Another possibility would be to publish
interim reports on grant-funded research. In the commercial sector, the
position was not simple. Negative results were rarely published, and for
reasons of commercial secrecy even positive results were not published
until a patent application had been lodged. If a new medicine failed to
reach the market neither positive nor negative results might ever be
published. In such circumstances the process of assessing the release of
any information would involve commercial lawyers more than scientists, and
it would be a lengthy, complex and iterative procedure. Because of those
problems, the Committee considered that a more detailed investigation of a
workable process should be undertaken.
8.10 The Chairman agreed that he would urge the Minister to commission
further examination of possible mechanisms for publishing negative
results, as the development of a satisfactory system could result
in a reduction of nugatory experiments
8.11 The Committee discussed the other recommendations in the majority
report and accepted the following:
- The Committee agreed with the recommendation of the working group
that total openness, as supported by a number of individuals' and
animal protection organisations' responses to the consultation
exercise, was not practical chiefly because of concerns in relation to
personal security, but also because of issues of commercial
confidentiality.
- No retrospective amendment to section 24 Any change relating to
animal experimentation should not be retrospective. The Committee
recognised that because a Project Licence lasted only five years,
changes to the disclosure of project licence information would be fully
achieved in that time scale.
- Increased openness regarding infringements The Committee noted
that summaries of major infringements were considered in an anonymised
form by the APC, and discussed at Committee meetings. In the case of a
more serious infringement a detailed anonymised account was supplied.
The Committee believed that information of that kind should be more
widely available and expressed willingness to publish the material as an
appendix to its annual report.
- Increased openness in statistical reporting The Committee noted
that annually, a statistical report on animal experimentation was
published, and recommended that the usefulness of the information in
that report should be improved. For example, it should include numbers
of animals kept for experimentation in addition to the existing
statistics, which detailed only numbers of animals actually used
in experiments. The Committee also recommended that the report should
include details of the severity of experiments. That would assist the
public to come to an informed view. Although an annual statistical
report was produced, there was no annual report of other areas of the
work of the Inspectors. The Committee recommended that there should be
such an annual report, which might cover areas such as visits to
establishments; the results, number and type of licences processed; and
the outcome of research renewal applications.
- Additional voluntary openness The Committee considered that in
order to assist public debate the Life Science institutions should be
encouraged to open their facilities to the responsible public.
- APC involvement in special investigations The Committee noted
that APC minutes were placed on the APC website. It recommended that in
the same way, where the APC discussed a report by an APC working group
carrying out a "quality assurance audit" of an investigation
by the Inspectorate, that discussion, the report of the audit working
group and the Inspectorate report should all be made available on the
APC website, suitably anonymised.
- APC interaction with other bodies The Committee agreed that it
should have a programme of regular interaction with other committees,
representative bodies and pressure groups in the UK and overseas. That
would be for two purposes: to educate and inform members of the APC; and
to achieve a mutual and reciprocal educational and information process
with other relevant influential bodies. In the UK this would include
bodies such as the House of Lords select committee on animal
experimentation, the Agriculture and Environment Biotechnology
Commission (AEBC), the United Kingdom Xenotransplantation Interim
Regulatory Authority (UKXIRA), and representatives of users and animal
protection organisations. The aim of international co-operation would be
to contribute towards the development of international Freedom of
Information legislation relating to animal experimentation, especially
within the European Union.
8.12 The Committee then discussed the proposal made by the working
group that a standing forum for public debate should be established. It
was agreed that the proposal needed further discussion, and should be an
agenda item at a future meeting. Action: Secretariat
8.13 At the end of the discussion on this item it was agreed that the
Chairman should write to the Minister reflecting the discussion which had
taken place and presenting the Committee's recommendations whilst noting
the continuing disagreements. The Chairman's letter would be circulated
to the Membership. It was agreed that the Chairman would submit a revised
report to the Minister in due course. Action: Secretariat [Secretary's
note: a copy of the Chairman's letter dated 3 January 2001 is
attached to these minutes. It was copied to the Membership the same day.]
9. Allegations by "Uncaged" about xenotransplantation work
at Imutran and HLS (INF(00) 30)
9.1 Before discussion began several members declared interests.
Professor Atterwill reminded the meeting that he was currently employed by
HLS, and offered to withdraw from the meeting. Professor Broom said that
he was a member of the HLS Ethical Review Process. Professor Bulfield said
that the Roslin Institute had, until three months previously been in
commercial competition with Imutran. Dr Jennings said that as part of her
RSPCA responsibilities she was engaged in preparing a report on the
allegations. Dr Langley said that from July to September 2000 she had
received payments for advising "Uncaged", but had no current
ongoing pecuniary interest. The Chief Inspector also offered to withdraw
from the meeting. It was agreed that having declared their interests, all
those identified should remain and participate in the discussion except
Professor Atterwill, because of his continuing interest. Professor
Atterwill then left the meeting.
9.2 In a brief discussion it was noted that the Secretary of State had
decided to ask the Chief Inspector to examine, as part of the Inspectorate's
normal statutory inspection and reporting function, the available evidence
relating to compliance with the authorities granted to Imutran for its
xenotransplantation work between 1995 and 2000. The Chief Inspector had
begun that examination. It was suggested that as a first step, the
Committee would find it helpful to ask the Minister if he could provide
some background on why a special investigation by the Inspectorate, as had
occurred with the allegations about Harlan-Hillcrest, had not been
commissioned. The Chairman agreed to write to the Minister. Action:
Secretariat
9.3 The Committee agreed that it would return to the issue when the
Chief Inspector had concluded his examination. Action: Secretariat
10. Any other business
10.1 Dr Jennings distributed a paper which she and Dr Jane Smith had
written about ethics training for licensees. She said that the paper was
particularly relevant to modules 1 and 5 of the current modular training
system.
10.2 Dr Jennings said that LASA were currently planning a meeting which
would consider the current Home Office modular licensing training system.
The Chairman asked whether Professor Holland, who had expressed an
interest in the element of the training relating to ethics, could be
involved. Dr Jennings agreed to take this forward. Action: Dr Jennings
11 Date of next meeting
11.1 Wednesday 14 February at the Home Office.
[Secretary's note: Owing to time constraints the
Committee were unable to discuss certain agenda items: Oral report by Home
Office on recent developments); Statistics of Scientific Procedures 1999;
and APC working methods. These will be carried forward to the agenda of
the meeting on 14 February 2001.]
Dear Mr O'Brien
ANIMAL PROCEDURES COMMITTEE: RECOMMENDATIONS ON OPENNESS
As you know, the Animal Procedures Committee has been
carrying out a consultation exercise on openness in relation to the use of
animals in scientific experiments. This letter presents you with the
Committee's advice on this important subject. Because of the tight
timetable I know you are working under, I am not presenting you with the
Committee's full report at this stage. However the Committee will in due
course publish a full report setting out the basis of our reasoning.
2. The consultation letter was sent out on 13 January
2000 and 2,320 responses were received. A working group of five APC
members had eight meetings between March and November to consider the
advice which should be offered. The working group submitted two reports to
the main Committee at a meeting on 13 December - a majority report,
supported by three of the members of the working group, and a minority
report, supported by the other two members of the working group.
3. At the meeting on 13 December, I sought a consensus
of views. After discussion, the Committee agreed that I should write to
you presenting recommendations for Home Office action. After careful
consideration, we have concluded that total openness, as supported by a
number of individuals' and animal protection organisations' responses,
is not practical chiefly because of concerns in relation to personal
security, but also because of issues of commercial confidentiality. Our
aim however, has been to recommend measures which will lead to the
greatest degree of openness compatible with those concerns. The two
most important recommendations are those relating to the revisions to
project licence applications, and to the publication of results of
experiments.
Recommendation 1: the Project Licence Application form
4. We recommend that the Project Licence
Application form should require a summary of the procedures to be
undertaken, and that this summary should be comprehensive and detailed
enough to provide a reader with a clear indication of the costs and
benefits of the project. Such a summary would be perhaps a maximum of two
pages, and would be written in language appropriate to the general reader.
We recommend that such a summary should include:-
- Key objectives and possible benefits of the project;
- Reasons for the need to use animals; what alternatives have been
considered; and why these are not appropriate;
- Reasons for the choice of species and strains;
- Numbers of animals to be used and kept for the specific project;
- What will happen to the animals as a result of the project - a
synopsis of the main adverse effects covering the lifetime experience
of the animal; including factors such as source, husbandry, procedures
and their effects, and eventual fate of the animal;
- Estimated level of the severity of the project;
- Specific measures to minimise adverse effects and improve welfare,
including both husbandry and procedures; and
- How the applicant has weighed the costs against the benefits to
judge whether the use of animals is justified.
5. The Committee recognised that there were advantages and
disadvantages to whether a summary of a licence application should be made
public at the stage when an application was received by the Home Office,
or later, at the stage when a licence was granted. If the application were
made public at the earlier stage:
- it would give members of the public time to comment before a licence
was granted, so that they could seek to influence the decision making
process;
- animal protection organisations might be able to refer to
possible alternative procedures which had not been considered;
- sight of applications which were ultimately turned down would allow
the public to see that the licensing process was sufficiently
rigorous.
6. On the other hand, it was also suggested that making
an application public before the licence had been granted:
- would hamper the iterative process of discussion which goes on
between the Home Office and applicants;
- as applications are progressively developed by that iterative
process, more than one version of a changing application would have to
be made public;
- until a licence is granted, the procedure has not been subject to an
exercise of governmental judgement, and therefore should not be made
public.
7. I hope that when the Home Office considers the stage
at which a summary of a project licence application should be made public,
the advantages and disadvantages of both options will be taken into
consideration.
Recommendation 2: Publication of results
8. Positive outcomes of experiments are usually
published in open scientific literature, but projects which yield no
useful results, or fail to prove a project or principle ("negative
results") are seldom written up - this is true, in particular, of
basic medical research. Failure to publish such results could lead to
unnecessary repetition of animal experimentation.
9. Mechanisms for making available information on both
positive and negative research outcomes would differ depending on whether
the research was basic medical research or commercial research. One
possible mechanism for basic medical research could be to record on the
ABCU website the results achieved or an explanation of why the project was
abandoned. The effort this would entail should not be underestimated and
would contribute little to academic progress. Another possibility would be
to publish interim reports on grant-funded research. In the commercial
sector, the position is not simple. Negative results are rarely published,
and for reasons of commercial secrecy even positive results are not
published until a patent application has been lodged. If a new medicine
fails to reach the market neither positive nor negative results may ever
be published. In such circumstances the process of assessing the release
of any information will involve commercial lawyers more than scientists,
and it will be a lengthy, complex and iterative procedure. Because of
these problems, we recommend that a more detailed investigation of a
workable process should be undertaken.
10. The Committee recognised that this was a
particularly difficult and complicated area. However, the Committee urges
you to commission further examination of possible mechanisms for
publishing negative results, as the development of a satisfactory
system could result in a reduction of nugatory experiments.
Recommendation 3: no retrospective amendment to section
24
11. Any change relating to animal experimentation
should not be retrospective. We recognised that because a Project Licence
lasts only five years, changes to the disclosure of project licence
information would be fully achieved in that time scale.
Recommendation 4: increased openness regarding
infringements
12. Summaries of major infringements are considered in an anonymised
form by the APC, and discussed at Committee meetings. In the case of a
more serious infringement a detailed anonymised account is supplied. We
believe that information of this kind should be more widely available and
we would be willing to publish this material as an appendix to our annual
report.
Recommendation 5: increased openness in statistical
reporting
13. Annually, a statistical report on animal
experimentation is published, available from HMSO. We recommend that the
usefulness of the information in that report should be improved. For
example, it should include numbers of animals kept for
experimentation in addition to the existing statistics, which detail only
numbers of animals actually used in experiments. We also recommend
that the report should include details of the severity of experiments.
This would assist the public to come to an informed view.
14. Although an annual statistical report is produced,
there is no annual report of other areas of the work of the Inspectors. We
recommend that there should be such an annual report, which might cover
areas such as visits to establishments; the results, number and type of
licences processed; and the outcome of research renewal applications.
Other recommendations
15. You will also wish to be aware of other
recommendations which the Committee agreed, although they are for the
Committee itself to pursue, rather than the Home Office.
Recommendation 6: additional voluntary openness
16. To assist public debate the Life Science
institutions should be encouraged to open their facilities to the
responsible public.
Recommendation 7: APC involvement in special
investigations
17. We note that APC minutes are placed on the APC
website. In the same way, where the APC discusses a report by an APC
working group carrying out a "quality assurance audit" of an
investigation by the Inspectorate, that discussion, the report of the
audit working group and the Inspectorate report should all be made
available on the web, suitably anonymised.
Recommendation 8: APC interaction with other bodies
18. The APC should have a programme of regular
interaction with other committees, representative bodies and pressure
groups in the UK and overseas. This would be for two purposes: to educate
and inform members of the APC; and to achieve a mutual and reciprocal
educational and information process with other relevant influential
bodies. In the UK this would include bodies such as the House of Lords
select committee on animal experimentation, the Agriculture and
Environment Biotechnology Commission (AEBC), the United Kingdom
Xenotransplantation Interim Regulatory Authority (UKXIRA), and
representatives of users and animal protection organisations. The aim of
international co-operation would be to contribute towards the development
of international Freedom of Information legislation relating to animal
experimentation, especially within the European Union.
19. On behalf of the Committee I commend these
recommendations to you. I hope that our advice will prove helpful to your
consideration of this difficult subject.
Yours sincerely
MICHAEL BANNER
|